Evidence-based recs issued for systemic care in psoriasis

Evidence-based recs issued for systemic care in psoriasis

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy with minimized toxicity, according to research published online Dec. 17 in JAMA Dermatology.

April W. Armstrong, M.D., M.P.H., from the University of Colorado Denver, and colleagues conducted a systematic review to develop evidence-based, best-practice recommendations for for appropriately selected patients with psoriasis. Group discussions and voting were employed by the Medical Board of the National Psoriasis Foundation.

The researchers found that there were few trials that assessed the efficacy and safety of combination therapy in moderate to severe psoriasis. Combining biologics, such as etanercept or adalimumab, with phototherapy reduced disease severity more than either agent alone. Etanercept and methotrexate were more effective in combination than as monotherapy. Compared with infliximab alone, the combination of infliximab and methotrexate resulted in greater efficacy. Etanercept dose could be reduced to maintain similar levels of efficacy with concomitant use of acitretin. Psoriasis flares could be controlled with short-term cyclosporine use combined with etanercept or adalimumab. The preferred order for combining a second modality with biologics was: biologic and methotrexate; biologic and acitretin combination; and biologic and combination. Insufficient data were available for combining biologics with acitretin, cyclosporine, or a second biologic.

"Among appropriately selected patients with , carefully chosen combinations may result in greater efficacy, while minimizing toxicity," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further

Treatment recommendations developed for nail psoriasis

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: JAMA Dermatology

Copyright © 2014 HealthDay. All rights reserved.

Citation: Evidence-based recs issued for systemic care in psoriasis (2014, December 19) retrieved 20 January 2022 from https://medicalxpress.com/news/2014-12-evidence-based-recs-issued-psoriasis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors